author_facet Scott, Linda M.
Scott, Mike A.
Campbell, Peter J.
Green, Anthony R.
Scott, Linda M.
Scott, Mike A.
Campbell, Peter J.
Green, Anthony R.
author Scott, Linda M.
Scott, Mike A.
Campbell, Peter J.
Green, Anthony R.
spellingShingle Scott, Linda M.
Scott, Mike A.
Campbell, Peter J.
Green, Anthony R.
Blood
Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
Cell Biology
Hematology
Immunology
Biochemistry
author_sort scott, linda m.
spelling Scott, Linda M. Scott, Mike A. Campbell, Peter J. Green, Anthony R. 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2006-04-018259 <jats:title>Abstract</jats:title> <jats:p>An acquired V617F JAK2 mutation occurs in patients with polycythemia vera (PV) or essential thrombocythemia (ET). In a proportion of V617F-positive patients, mitotic recombination produces mutation-homozygous cells that come to predominate with time. However, the prevalence of homozygosity is unclear, as previous reports studied mixed populations of wild-type, V617F-heterozygous, and V617F-homozygous mutant cells. We therefore analyzed 1766 individual hematopoietic colonies from 34 patients with PV or ET in whom granulocyte sequencing demonstrated that the mutant peak did not predominate. V617F-positive erythroid burst-forming units (BFU-Es) were more frequent in patients with PV compared with patients with ET (P = .022) and, strikingly, V617F-homozygous BFU-Es were detected in all 17 patients with PV, but in none of the patients with ET (P &lt; .001). Moreover, mutation-homozygous cells were present in 2 patients with ET after polycythemic transformation. These results demonstrate that V617F-homozygous erythroid progenitors are present in most patients with PV but occur rarely in those with ET.</jats:p> Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia Blood
doi_str_mv 10.1182/blood-2006-04-018259
facet_avail Online
Free
finc_class_facet Biologie
Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDA2LTA0LTAxODI1OQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDA2LTA0LTAxODI1OQ
institution DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
imprint American Society of Hematology, 2006
imprint_str_mv American Society of Hematology, 2006
issn 0006-4971
1528-0020
issn_str_mv 0006-4971
1528-0020
language English
mega_collection American Society of Hematology (CrossRef)
match_str scott2006progenitorshomozygousforthev617fmutationoccurinmostpatientswithpolycythemiaverabutnotessentialthrombocythemia
publishDateSort 2006
publisher American Society of Hematology
recordtype ai
record_format ai
series Blood
source_id 49
title Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_unstemmed Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_full Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_fullStr Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_full_unstemmed Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_short Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_sort progenitors homozygous for the v617f mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
topic Cell Biology
Hematology
Immunology
Biochemistry
url http://dx.doi.org/10.1182/blood-2006-04-018259
publishDate 2006
physical 2435-2437
description <jats:title>Abstract</jats:title> <jats:p>An acquired V617F JAK2 mutation occurs in patients with polycythemia vera (PV) or essential thrombocythemia (ET). In a proportion of V617F-positive patients, mitotic recombination produces mutation-homozygous cells that come to predominate with time. However, the prevalence of homozygosity is unclear, as previous reports studied mixed populations of wild-type, V617F-heterozygous, and V617F-homozygous mutant cells. We therefore analyzed 1766 individual hematopoietic colonies from 34 patients with PV or ET in whom granulocyte sequencing demonstrated that the mutant peak did not predominate. V617F-positive erythroid burst-forming units (BFU-Es) were more frequent in patients with PV compared with patients with ET (P = .022) and, strikingly, V617F-homozygous BFU-Es were detected in all 17 patients with PV, but in none of the patients with ET (P &lt; .001). Moreover, mutation-homozygous cells were present in 2 patients with ET after polycythemic transformation. These results demonstrate that V617F-homozygous erythroid progenitors are present in most patients with PV but occur rarely in those with ET.</jats:p>
container_issue 7
container_start_page 2435
container_title Blood
container_volume 108
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792339027168329729
geogr_code not assigned
last_indexed 2024-03-01T15:41:34.716Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Progenitors+homozygous+for+the+V617F+mutation+occur+in+most+patients+with+polycythemia+vera%2C+but+not+essential+thrombocythemia&rft.date=2006-10-01&genre=article&issn=1528-0020&volume=108&issue=7&spage=2435&epage=2437&pages=2435-2437&jtitle=Blood&atitle=Progenitors+homozygous+for+the+V617F+mutation+occur+in+most+patients+with+polycythemia+vera%2C+but+not+essential+thrombocythemia&aulast=Green&aufirst=Anthony+R.&rft_id=info%3Adoi%2F10.1182%2Fblood-2006-04-018259&rft.language%5B0%5D=eng
SOLR
_version_ 1792339027168329729
author Scott, Linda M., Scott, Mike A., Campbell, Peter J., Green, Anthony R.
author_facet Scott, Linda M., Scott, Mike A., Campbell, Peter J., Green, Anthony R., Scott, Linda M., Scott, Mike A., Campbell, Peter J., Green, Anthony R.
author_sort scott, linda m.
container_issue 7
container_start_page 2435
container_title Blood
container_volume 108
description <jats:title>Abstract</jats:title> <jats:p>An acquired V617F JAK2 mutation occurs in patients with polycythemia vera (PV) or essential thrombocythemia (ET). In a proportion of V617F-positive patients, mitotic recombination produces mutation-homozygous cells that come to predominate with time. However, the prevalence of homozygosity is unclear, as previous reports studied mixed populations of wild-type, V617F-heterozygous, and V617F-homozygous mutant cells. We therefore analyzed 1766 individual hematopoietic colonies from 34 patients with PV or ET in whom granulocyte sequencing demonstrated that the mutant peak did not predominate. V617F-positive erythroid burst-forming units (BFU-Es) were more frequent in patients with PV compared with patients with ET (P = .022) and, strikingly, V617F-homozygous BFU-Es were detected in all 17 patients with PV, but in none of the patients with ET (P &lt; .001). Moreover, mutation-homozygous cells were present in 2 patients with ET after polycythemic transformation. These results demonstrate that V617F-homozygous erythroid progenitors are present in most patients with PV but occur rarely in those with ET.</jats:p>
doi_str_mv 10.1182/blood-2006-04-018259
facet_avail Online, Free
finc_class_facet Biologie, Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDA2LTA0LTAxODI1OQ
imprint American Society of Hematology, 2006
imprint_str_mv American Society of Hematology, 2006
institution DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275
issn 0006-4971, 1528-0020
issn_str_mv 0006-4971, 1528-0020
language English
last_indexed 2024-03-01T15:41:34.716Z
match_str scott2006progenitorshomozygousforthev617fmutationoccurinmostpatientswithpolycythemiaverabutnotessentialthrombocythemia
mega_collection American Society of Hematology (CrossRef)
physical 2435-2437
publishDate 2006
publishDateSort 2006
publisher American Society of Hematology
record_format ai
recordtype ai
series Blood
source_id 49
spelling Scott, Linda M. Scott, Mike A. Campbell, Peter J. Green, Anthony R. 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2006-04-018259 <jats:title>Abstract</jats:title> <jats:p>An acquired V617F JAK2 mutation occurs in patients with polycythemia vera (PV) or essential thrombocythemia (ET). In a proportion of V617F-positive patients, mitotic recombination produces mutation-homozygous cells that come to predominate with time. However, the prevalence of homozygosity is unclear, as previous reports studied mixed populations of wild-type, V617F-heterozygous, and V617F-homozygous mutant cells. We therefore analyzed 1766 individual hematopoietic colonies from 34 patients with PV or ET in whom granulocyte sequencing demonstrated that the mutant peak did not predominate. V617F-positive erythroid burst-forming units (BFU-Es) were more frequent in patients with PV compared with patients with ET (P = .022) and, strikingly, V617F-homozygous BFU-Es were detected in all 17 patients with PV, but in none of the patients with ET (P &lt; .001). Moreover, mutation-homozygous cells were present in 2 patients with ET after polycythemic transformation. These results demonstrate that V617F-homozygous erythroid progenitors are present in most patients with PV but occur rarely in those with ET.</jats:p> Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia Blood
spellingShingle Scott, Linda M., Scott, Mike A., Campbell, Peter J., Green, Anthony R., Blood, Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia, Cell Biology, Hematology, Immunology, Biochemistry
title Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_full Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_fullStr Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_full_unstemmed Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_short Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_sort progenitors homozygous for the v617f mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
title_unstemmed Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia
topic Cell Biology, Hematology, Immunology, Biochemistry
url http://dx.doi.org/10.1182/blood-2006-04-018259